OM:BIOA BBiotechs
How Leqembi's Finnish Launch at BioArctic (OM:BIOA B) Has Changed Its Investment Story
BioArctic AB announced that Leqembi has now become available for Alzheimer's treatment at a private clinic in Finland, with the first patient having started therapy following European Commission approval earlier this year.
This real-world rollout signals the advance of disease-modifying therapies for Alzheimer's in the Nordic region and reflects BioArctic's move toward broader commercialization.
We’ll now explore how the clinical adoption of Leqembi in Finland may influence BioArctic’s...